Contact: B. D. Colen
Caption: Harvard Stem Cell Institute scientists, lead by Kiran Musunuru collaborating with researchers at the University of Pennsylvania have developed a "genome-editing" approach for permanently reducing cholesterol levels in mice through a single injection, a development that could reduce the risk of heart attacks in humans by 40 to 90 percent.
Credit: B. D. Colen/Harvard University
Usage Restrictions: Image may only be used in conjunction with attached story.
Related news release: A shot against heart attacks?